News

Displaying 1 - 20 of 58

Colorado publishes latest statistics on impact of cannabis legalisation

This news item was published in the EMCDDA’s Cannabis drug policy news on 17.12.2018 In the US state of Colorado, use and sale of cannabis for recreational purposes has been legal since...

Registration now open for the eighth European drugs summer school

The University Institute of Lisbon (ISCTE-IUL) and the EU drugs agency (EMCDDA) will be joining forces once again next summer to hold the eighth European drugs summer school (EDSS) on ‘Illicit drugs...

photo of the EMCDDA premises

Board re-elects French member Laura d’Arrigo as Chair and Austrian member Franz Pietsch as Vice-Chair

The EMCDDA Management Board, meeting in Lisbon this week, held elections today for the positions of Chair and Vice-Chair of the Board. Laura d’Arrigo (France), Diplomatic advisor at the French Interministerial Mission...

lines of cocaine on a mirror alongside a razor blade

Innovative EMCDDA monitoring method sheds light on changes in Europe’s cocaine market

The latest changes in Europe’s cocaine market are explored in a new report published today by the EU drugs agency (EMCDDA). The report follows an analysis in the European Drug Report 2018...

EMCDDA takes stock of EU-ANSA activities in 2018

This month, the EMCDDA approaches the end of its presidency of the EU Agencies’ Network on Scientific Advice (EU-ANSA) and looks back on a productive year (1). EU-ANSA is one of the...

Signature of working arrangements with five EU agencies

Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) has been significantly strengthened thanks to new legislation applying from 23 November (1). The...

EU drugs agency publishes its first report on the medical use of cannabis

What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue...

Reitox academy: professionalising the prevention workforce through standardised training

Over 50 representatives of the Reitox national focal points (NFPs) and decision-makers from more than 20 countries will gather in Prague this week for a Reitox academy on the theme of prevention...

microphone

Expert meeting to examine implementation of evidence-based interventions on drugs

Experts in the implementation of evidence-based interventions from Europe and North America are gathering at the EMCDDA this week for the agency’s first technical meeting on ‘Pathways to implementation’. Implementing responses to...

New legislation, bringing faster response to new drugs, applies from today

Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) will be significantly strengthened, thanks to new legislation applying from today (1). The legislation...

Canada’s cannabis legalisation enters into force

This news item was published in the EMCDDA’s Cannabis drug policy news on 16.11.2018 In Canada, a law to legalise recreational use of cannabis, which had been proposed in the Liberal party’s...

Monitoring drug use in recreational settings across Europe — new report out today

How to build a better picture of substance use in recreational settings is explored today in a new EMCDDA report: Monitoring drug use in recreational settings across Europe: conceptual challenges and methodological...

scientific award

Annual award celebrates excellence in scientific writing on illicit drugs

Winners of the 2018 EMCDDA scientific award were announced by the EU drugs agency today in the margins of its 49th Scientific Committee meeting in Lisbon (1). The acclaimed writers will be...

paper chain

2018 Reitox week focuses on ‘futures’

Representatives of candidate, potential candidate and neighbouring countries of the EU and countries of Central Asia are joining members of the EMCDDA’s Reitox network (1) in Lisbon from 12–16 November for the...

Prevention technologies — European prevention conference opens today

What do we know about how research evidence is used in the ‘real world’ of prevention? How can we take advantage of technology to promote the use of evidence in policy and...

Lisbon to host Third European conference on addictive behaviours and dependencies — Registration and call for abstracts now open

Leading international experts in the field of addiction science will meet in Lisbon from 23–25 October 2019 for the Third European conference on addictive behaviours and dependencies. The theme of the conference...

Euro-DEN thumbnail

New EMCDDA Paper explores the illicit captagon market

What is captagon? Where is it used and produced? Can it be linked to terrorist attacks in Europe? These are some of the questions explored in the latest edition in the EMCDDA...

Alexis Goosdeel pays official visit to Cyprus

EMCDDA Director Alexis Goosdeel is paying an official visit to Cyprus today, where he is meeting with health and security officials. This is in line with the EMCDDA Strategy 2025, which aims...

market

Low-THC cannabis products being sold in the EU – key legal issues

This news item was published in the EMCDDA’s Cannabis drug policy news on 09.10.2018 Since 2017, herbal cannabis and cannabis oils have been offered for open sale in health food shops or...

Man and woman shaking hands (close-up)

EMCDDA and the Republic of Albania strengthen their cooperation

EMCDDA Director Alexis Goosdeel is participating this week in the EU-Western Balkans Ministerial Forum on Justice and Home Affairs, taking place from 4–5 October in Tirana. Organised under the auspices of the...